OR WAIT null SECS
eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of elluminate®.
MANSFIELD, MA – January 20, 2015
– eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of the latest version of their end to end clinical data repository and analytics platform, elluminate
. The elluminate
platform integrates and standardizes clinical and operational data, regardless of source, to enable advanced analytics and adhoc reporting capabilities. This release enhances the ability to visualize operational data such as metrics, audit trail, and queries to support risk based monitoring and site management. The release also enhances the ability to define workflows to support advanced data integrations. "We have a unique perspective on industry needs to support clinical drug development," explains Robert Arnesen, President eClinical Solutions. "Our experience in clinical data management coupled with feedback from existing clients enables us to shape our platform to meet the day-to-day needs of clinical and operational personnel." elluminate
is a breakthrough technology built specifically to help the life sciences industry aggregate and standardize disparate data from multiple sources, and allows users to perform analytics and view data across trials. With feedback from clients, and their teams leveraging the platform daily, they continue the innovation based on "real world" use and experience in clinical development. "With elluminate
we strive to make clinical research data acquisition, standardization, aggregation, and analytics absolutely simple and easy," says Raj Indupuri, CEO of eClinical Solutions. "Allowing complete transparency and access to all clinical and operational data through powerful analytics empowers personnel to be more responsive to development and business needs," says Indupuri. In addition, elluminate
provides standards compliance, metadata management, and document management capabilities in a cloud based 21 CFR Part 11 compliant environment. "Our platform has helped clients expedite clinical research development and aid in making better decisions faster," says Indupuri. "We will continue to innovate to further empower the industry and assist our clients to bring needed therapies to market."